{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:36:44Z","timestamp":1792031804485,"version":"4.4.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10620-017-4679-7","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T06:55:30Z","timestamp":1500360930000},"page":"2231-2240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Gastroparesis: Medical and Therapeutic Advances"],"prefix":"10.1007","volume":"62","author":[{"given":"Christopher M.","family":"Navas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"4679_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2012.373","volume":"108","author":"M Camilleri","year":"2013","unstructured":"Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18\u201337.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1053\/j.gastro.2004.09.054","volume":"127","author":"HP Parkman","year":"2004","unstructured":"Parkman HP, Hasler WL, Fisher RS, for the American Gastroenterological Association, et al. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589\u20131591.","journal-title":"Gastroenterology"},{"key":"4679_CR3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1572-0241.2000.02076.x","volume":"95","author":"G Tougas","year":"2000","unstructured":"Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456\u20131462.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1572-0241.2007.01636.x","volume":"103","author":"TL Abell","year":"2008","unstructured":"Abell TL, Camilleri M, Donohue K, et al. Consensus recommendations for gastric empting Scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103:753\u2013763.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/j.gastro.2008.12.047","volume":"136","author":"HK Jung","year":"2009","unstructured":"Jung HK, Choung RS, Locke GR, et al. The incidence, prevalence and outcomes of patients with gastroparesis in Olmsted County, Minnesota from 1996 to 2006. Gastroenterology. 2009;136:1225\u20131233.","journal-title":"Gastroenterology"},{"key":"4679_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000728","author":"BE Lacy","year":"2016","unstructured":"Lacy BE, Crowell MD, Mathis C, Bauer D, Heinberg LJ. Gastroparesis: quality of life and health care utilization. J Clin Gastroenterol. 2016. doi: 10.1097\/MCG.0000000000000728 .","journal-title":"J Clin Gastroenterol"},{"key":"4679_CR7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1023\/B:QURE.0000021689.86296.e4","volume":"13","author":"DA Revicki","year":"2004","unstructured":"Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Quality Life Res. 2004;13:833\u2013844.","journal-title":"Quality Life Res"},{"key":"4679_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1572-0241.2007.01658.x","volume":"103","author":"YR Wang","year":"2008","unstructured":"Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995\u20132004. Am J Gastroenterol. 2008;103:313\u2013322.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1023\/A:1026665728213","volume":"43","author":"I Soykan","year":"1998","unstructured":"Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398\u20132404.","journal-title":"Dig Dis Sci"},{"key":"4679_CR10","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1023\/A:1021036601462","volume":"47","author":"H Pande","year":"2002","unstructured":"Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of 5 cases. Dig Dis Sci. 2002;47:2664\u20132668.","journal-title":"Dig Dis Sci"},{"key":"4679_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00265086","volume":"32","author":"M Horowitz","year":"1989","unstructured":"Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia. 1989;32:151\u2013159.","journal-title":"Diabetologia"},{"key":"4679_CR12","first-page":"637","volume":"32","author":"P Enck","year":"1994","unstructured":"Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32:637\u2013641.","journal-title":"Z Gastroenterol"},{"key":"4679_CR13","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1001\/archinte.160.18.2808","volume":"160","author":"D Maleki","year":"2000","unstructured":"Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808\u20132816.","journal-title":"Arch Intern Med"},{"key":"4679_CR14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1001\/archinte.161.16.1989","volume":"161","author":"P Bytzer","year":"2001","unstructured":"Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989\u20131996.","journal-title":"Arch Intern Med"},{"key":"4679_CR15","doi-asserted-by":"publisher","unstructured":"Bharucha AE, Camilleri M, Veil E, et al. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013; 25. doi: 10.1111\/nmo.12054 .","DOI":"10.1111\/nmo.12054"},{"key":"4679_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2036.2007.03564.x","volume":"27","author":"B Kuo","year":"2008","unstructured":"Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labeled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27:186\u2013196.","journal-title":"Aliment Pharmacol Ther"},{"key":"4679_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01314461","volume":"24","author":"MS Perkel","year":"1979","unstructured":"Perkel MS, Moore C, Hersh T, Davidson E. Metoclopramide therapy in patient with delayed gastric emptying. Dig Dis Sci. 1979;24:9.","journal-title":"Dig Dis Sci"},{"key":"4679_CR18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/nmo.12296","volume":"26","author":"HP Parkman","year":"2014","unstructured":"Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol Motil. 2014;26:521\u2013528.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.cgh.2014.12.030","volume":"13","author":"HP Parkman","year":"2015","unstructured":"Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray reduces symptoms of gastroparesis in women, but not men, with diabetes: results of a phase 2B randomized study. Clin Gastroenterol Hepatol. 2015;13:1256\u20131263.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4679_CR20","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1210\/jc.2006-2756","volume":"92","author":"N Wierup","year":"2007","unstructured":"Wierup N, Bjorkqvist M, Westrom B, Pierzynowski S, Sundler F, Sjolund K. Ghrelin and motilin are cosecreted from a prominent endocrine population in the small intestine. J Clin Endocrinol Metab. 2007;92:3573\u20133581.","journal-title":"J Clin Endocrinol Metab"},{"key":"4679_CR21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1152\/ajpgi.00536.2006","volume":"292","author":"AJ Page","year":"2007","unstructured":"Page AJ, Slattery JA, Milte C, et al. Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferent. Am J Physiol Gastrointest Liver Physiol. 2007;292:1376\u20131384.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4679_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.2004.060426","volume":"55","author":"J Tack","year":"2006","unstructured":"Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55:327\u2013333.","journal-title":"Gut"},{"key":"4679_CR23","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10620-008-0622-2","volume":"54","author":"IA Harch","year":"2009","unstructured":"Harch IA, Koebnick C, Tasi AM, Hahn EG, Konturek PC. Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying. Dig Dis Sci. 2009;54:2161\u20132166.","journal-title":"Dig Dis Sci"},{"key":"4679_CR24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/nmo.12226","volume":"25","author":"M Camilleri","year":"2013","unstructured":"Camilleri M, Acosta A. A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let\u2019s not throw the baby out with the bath water. Neurogastrienteol Motil. 2013;25:859\u2013863.","journal-title":"Neurogastrienteol Motil"},{"key":"4679_CR25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-015-0430-8","volume":"17","author":"A Shin","year":"2015","unstructured":"Shin A, Wo JM. Therapeutic applications of ghrelin agonists in the treatment of gastroparesis. Curr Gastroenterol Rep. 2015;17:8.","journal-title":"Curr Gastroenterol Rep"},{"key":"4679_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2014.06.003","volume":"109","author":"L Ploeg Van der","year":"2014","unstructured":"Van der Ploeg L, Laken H, Sharma S, et al. Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sci. 2014;109:20\u201329.","journal-title":"Life Sci"},{"issue":"3","key":"4679_CR27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/nmo.12490","volume":"27","author":"M Camilleri","year":"2015","unstructured":"Camilleri M, Acosta A. Relamorelin: a novel gastricolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015;27:324\u2013332.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR28","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/nmo.12870","volume":"28","author":"AD Nelson","year":"2016","unstructured":"Nelson AD, Camilleri M, Acosta A, et al. Effects of gherelin receptor agonist, Relamorelin, on gastric motor functions and satiation in healthy volunteers. Neurogastroenterol Motil. 2016;28:1705\u20131713.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/dc12-1128","volume":"36","author":"A Shin","year":"2013","unstructured":"Shin A, Camilleri M, Busciglio I, et al. Randomized controlled phase IB study of ghrelin agonist, RM-131 in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013;36:41\u201348.","journal-title":"Diabetes Care"},{"key":"4679_CR30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.cgh.2013.04.019","volume":"11","author":"A Shin","year":"2013","unstructured":"Shin A, Camilleri M, Busciglio I, et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013;11:1453\u20131459.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4679_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.gastro.2016.03.038","volume":"151","author":"A Lembo","year":"2016","unstructured":"Lembo A, Camilleri M, McCallum R, et al. Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis. Gastroenterology. 2016;151:87\u201396.","journal-title":"Gastroenterology"},{"key":"4679_CR32","doi-asserted-by":"crossref","unstructured":"Camilleri M, McCallum R, Tack J, Spence S, Gottesdiener K, Fiedorek F. Relamorelin in patients with diabetic gastroparesis: Efficacy and safety results from a phase 2B randomized, double-blind, placebo-controlled, 12\u00a0week study. DDW. 2017; Abstract 638","DOI":"10.1016\/S0016-5085(17)30796-5"},{"key":"4679_CR33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11894-009-0058-7","volume":"11","author":"WL Hasler","year":"2009","unstructured":"Hasler WL. Serotonin and the GI tract. Curr Gastroenterol Rep. 2009;11:383\u2013391.","journal-title":"Curr Gastroenterol Rep"},{"key":"4679_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/JEP.S68880","volume":"6","author":"T Ottoboni","year":"2014","unstructured":"Ottoboni T, Gelder MS, O\u2019Boyle E. Biochronomer technology and the development of APF530, a sustained release formulation of granisetron. J Exp Pharm. 2014;6:15\u201321.","journal-title":"J Exp Pharm"},{"key":"4679_CR35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00520-010-0990-y","volume":"19","author":"RV Boccia","year":"2011","unstructured":"Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM. Sancuso study group. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy. Support Care Cancer. 2011;19:1609\u20131617.","journal-title":"Support Care Cancer"},{"key":"4679_CR36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(24)38946-3","volume":"295","author":"YA Kuryshev","year":"2000","unstructured":"Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D. Interactions of the 5-Hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Phamacol Exp Ther. 2000;295:614\u2013620.","journal-title":"J Phamacol Exp Ther"},{"key":"4679_CR37","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-11-2785","volume":"18","author":"JW Manson","year":"2012","unstructured":"Manson JW, Selness DS, Moon TE, O\u2019Mahony B, Donachie P, Howell J. Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron. Clin Cancer Res. 2012;18:2913\u20132921.","journal-title":"Clin Cancer Res"},{"key":"4679_CR38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10620-014-3097-3","volume":"59","author":"K Simmons","year":"2014","unstructured":"Simmons K, Parkman HP. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis. Dig Dis Sci. 2014;59:1231\u20131234.","journal-title":"Dig Dis Sci"},{"key":"4679_CR39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.5056\/jnm15203","volume":"22","author":"D Midani","year":"2016","unstructured":"Midani D, Parkman HP. Granisetron transdermal system for treatment of symptoms of gastroparesis: a prescription registry study. J Neurogastroenterol Motil. 2016;22:650\u2013655.","journal-title":"J Neurogastroenterol Motil"},{"key":"4679_CR40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0031-6997(25)06935-2","volume":"47","author":"MR Briejer","year":"1995","unstructured":"Briejer MR, Akkermans LM, Schuurkes JA. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol Rev. 1995;47:631\u2013651.","journal-title":"Pharmacol Rev"},{"key":"4679_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","volume":"20","author":"JH Maeyer De","year":"2008","unstructured":"De Maeyer JH, Lefebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil. 2008;20:99\u2013112.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2036.2012.05011.x","volume":"35","author":"J Tack","year":"2012","unstructured":"Tack J, Camilleri M, Chang L. Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35:745\u2013767.","journal-title":"Aliment Pharmacol Ther"},{"key":"4679_CR43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248409340158","volume":"14","author":"JL Anderson","year":"2009","unstructured":"Anderson JL, May HT, Blair TL, Muhlestein JB, Horne BD, Carlquist JF. Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control study. J Cardiovasc Pharmacol Ther. 2009;14:170\u2013175.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"4679_CR44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/nmo.12736","volume":"28","author":"J Tack","year":"2016","unstructured":"Tack J, Rotondo A, Meulemans A, Thielemans L, Cools M. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist Revexepride in patients with symptoms suggestive of gastroparesis. Neurogastroenterol Motil. 2016;28:487\u2013497.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR45","first-page":"1230","volume":"94","author":"D Patterson","year":"1999","unstructured":"Patterson D, Abell T, Rothstein R, Koch K, Barnett J. A double-blind multicenter comparison of Domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 1999;94:1230\u20131234.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1572-0241.2000.01721.x","volume":"95","author":"DL Dumitrascu","year":"2000","unstructured":"Dumitrascu DL, Weinbeck M. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis. Am J Gastroenterol. 2000;95:316\u2013317.","journal-title":"Am J Gastroenterol"},{"key":"4679_CR47","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1572-0241.2007.01411.x","volume":"102","author":"SC Reddymasu","year":"2007","unstructured":"Reddymasu SC, Soykan I, McCallum RW. Doperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastrienterol. 2007;102:2016\u20132045.","journal-title":"Am J Gastrienterol"},{"key":"4679_CR48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cgh.2008.02.065","volume":"6","author":"A Sugumar","year":"2008","unstructured":"Sugumar A, Singh A, Pasricha PK. A systematic review of the efficacy of Domperidone for the treatment of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2008;6:726\u2013733.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4679_CR49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00003495-200060030-00002","volume":"60","author":"P Diemunsch","year":"2000","unstructured":"Diemunsch P, Grelot L. Potential of substance P antagonists as antiemetics. Drugs. 2000;60:533\u2013546.","journal-title":"Drugs"},{"key":"4679_CR50","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","volume":"21","author":"PJ Hesketh","year":"2003","unstructured":"Hesketh PJ, Grunberg SM, Gralla RJ, et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. J Clin Oncol. 2003;21:4112\u20134119.","journal-title":"J Clin Oncol"},{"key":"4679_CR51","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/cncr.30054","volume":"122","author":"PJ Hesketh","year":"2016","unstructured":"Hesketh PJ, Schnadig ID, Schwartzberg LS, et al. Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy. Cancer. 2016;122:2418\u20132425.","journal-title":"Cancer"},{"key":"4679_CR52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10147-015-0928-y","volume":"21","author":"H Yahata","year":"2016","unstructured":"Yahata H, Kobayashi H, Sonoda K, et al. Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen. Int J Clin Oncol. 2016;21:491\u2013497.","journal-title":"Int J Clin Oncol"},{"key":"4679_CR53","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1345\/aph.1R484","volume":"46","author":"J Fahler","year":"2012","unstructured":"Fahler J, Wall GC, Leman BI. Gastroparesis-associated refractory nausea treated with aprepitant. Ann Pharmacother. 2012;46:e38.","journal-title":"Ann Pharmacother"},{"key":"4679_CR54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autneu.2016.07.004","volume":"202","author":"J Wellington","year":"2017","unstructured":"Wellington J, Scott B, Kundu S, Stuart P, Koch KL. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis. Auton Neurosci. 2017;202:56\u201361.","journal-title":"Auton Neurosci"},{"issue":"suppl","key":"4679_CR55","first-page":"2","volume":"45","author":"JO Clarke","year":"2013","unstructured":"Clarke JO, Sharaiha RZ, Kord VA, Lee LA, Kalloo AN, Khashab MA. Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy. 2013;45(suppl):2.","journal-title":"Endoscopy"},{"key":"4679_CR56","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.gie.2015.06.051","volume":"82","author":"MA Khashab","year":"2015","unstructured":"Khashab MA, Besharati S, Ngamruengphong S, et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation. Gastrointest Endosc. 2015;82:1106\u20131109.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR57","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11605-011-1607-6","volume":"15","author":"ML Hibbard","year":"2011","unstructured":"Hibbard ML, Dunst CM, Swanstrom LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg. 2011;15:1513\u20131519.","journal-title":"J Gastrointest Surg"},{"key":"4679_CR58","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00464-015-4385-5","volume":"30","author":"Shada Al","year":"2016","unstructured":"Al Shada, Dunst CM, Pescarus R, et al. Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc. 2016;30:1326\u20131332.","journal-title":"Surg Endosc"},{"key":"4679_CR59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-015-3837-z","volume":"61","author":"J Heckert","year":"2016","unstructured":"Heckert J, Sankineni A, Hughes WB, Harbison S, Parkman H. Gastric electric stimulation for refractory gastroparesis: a prospective analysis. Dig Dis Sci. 2016;61:169\u2013175.","journal-title":"Dig Dis Sci"},{"key":"4679_CR60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gtc.2014.11.012","volume":"44","author":"L Sarosiek","year":"2015","unstructured":"Sarosiek L, Davis B, Eichler E, McCallum RW. Surgical approaches to treatment of gastroparesis: gastric electrical stimulation, pyloroplasty, total gastrectomy and enteral feeding tubes. Gastroenterol Clin N Am. 2015;44:151\u2013167.","journal-title":"Gastroenterol Clin N Am"},{"key":"4679_CR61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.gie.2011.05.022","volume":"74","author":"TL Abel","year":"2011","unstructured":"Abel TL, Johnson WD, Kedar A, et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc. 2011;74:496\u2013503.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gie.2012.03.177","volume":"76","author":"S Deb","year":"2012","unstructured":"Deb S, Tang SJ, Abell TL, et al. Development of innovative techniques for the endoscopic implantation and securing of a novel, wireless, miniature gastrostimulator. Gastrointest Endosc. 2012;76:179\u2013184.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00464-012-2407-0","volume":"27","author":"J Zehetner","year":"2013","unstructured":"Zehetner J, Ravari F, Ayazi S, et al. Minimally invasive surgical approach for the treatment of gastroparesis. Surg Endosc. 2013;27:61\u201366.","journal-title":"Surg Endosc"},{"key":"4679_CR64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11605-014-2609-y","volume":"19","author":"NH Bhayani","year":"2015","unstructured":"Bhayani NH, Sharata AM, Dunst CM, Kurian AA, Reavis KM, Swanstrom LL. End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis. J Gastrointest Surg. 2015;19:411\u2013417.","journal-title":"J Gastrointest Surg"},{"key":"4679_CR65","unstructured":"Bagloo M, Besseler M, Ude A. Sleeve gastrectomy for the treatment of diabetic gastroparesis. In Proceedings 12th World Congress of Endoscopic Surgery, April 14\u201317, 2010 Landover, p. 521."},{"key":"4679_CR66","unstructured":"Meyer A, Pallati P, Shaligram A, et al. Partial longitudinal gastrectomy: a novel curative approach for gastroparesis. In Proceedings of the 2012 Annual Meeting of the Society of American Gastrointestinal Endoscopic Surgeons, San Diego, p. 249."},{"key":"4679_CR67","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.gie.2013.07.019","volume":"78","author":"MA Khashab","year":"2013","unstructured":"Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy. Gastrointest Endosc. 2013;78:764\u2013768.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2017.01.031","author":"S Dacha","year":"2017","unstructured":"Dacha S, Mekaroonkamol P, Li L, et al. Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy. Gastrointest Endosc. 2017. doi: 10.1016\/j.gie.2017.01.031 .","journal-title":"Gastrointest Endosc"},{"key":"4679_CR69","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.gie.2016.07.050","volume":"85","author":"JM Gonazlez","year":"2017","unstructured":"Gonazlez JM, Lestelle V, Benezech A, et al. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis. Gastrointest Endosc. 2017;85:132\u2013139.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.gie.2016.06.048","volume":"85","author":"MA Khashab","year":"2017","unstructured":"Khashab MA, Ngamruengphong S, Carr-Locke D, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy. Gastrointest Endosc. 2017;85:123\u2013128.","journal-title":"Gastrointest Endosc"},{"key":"4679_CR71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0016-5085(85)90589-X","volume":"89","author":"SK Sarna","year":"1985","unstructured":"Sarna SK. Cyclic motor activity; migrating motor complex. Gastroenterology. 1985;89:894\u2013913.","journal-title":"Gastroenterology"},{"key":"4679_CR72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1476-5381.2012.02009.x","volume":"167","author":"J Broad","year":"2012","unstructured":"Broad J, Mukherjee S, Samadi M, Martin J, Dukes G, Sanger G. Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists. Br J Pharmacol. 2012;167:763\u2013774.","journal-title":"Br J Pharmacol"},{"key":"4679_CR73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrgastro.2015.163","volume":"13","author":"GJ Sanger","year":"2016","unstructured":"Sanger GJ, Furness JB. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol.. 2016;13:38\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"4679_CR74","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/jpet.104.081497","volume":"313","author":"L Thielemans","year":"2005","unstructured":"Thielemans L, Depoortere I, Perret J, et al. Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther. 2005;313:1397\u20131405.","journal-title":"J Pharmacol Exp Ther"},{"key":"4679_CR75","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1046\/j.1365-2036.1997.00260.x","volume":"11","author":"MA Verhagen","year":"1997","unstructured":"Verhagen MA, Samsom M, Maes B, Geypens BJ, Ghoos YF, Smout AJ. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther. 1997;11:1077\u20131086.","journal-title":"Aliment Pharmacol Ther"},{"key":"4679_CR76","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"NJ Talley","year":"2000","unstructured":"Talley NJ, Verlinden M, Snape W, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying. Aliment Pharmacol Ther. 2000;14:1653\u20131661.","journal-title":"Aliment Pharmacol Ther"},{"key":"4679_CR77","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.49.3.395","volume":"49","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitius. Gut. 2001;49:395\u2013401.","journal-title":"Gut"},{"key":"4679_CR78","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2007.03461.x","volume":"26","author":"RW McCallum","year":"2007","unstructured":"McCallum RW, Cynshi O. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis. Aliment Pharmacol Ther. 2007;26:1121\u20131130.","journal-title":"Aliment Pharmacol Ther"},{"key":"4679_CR79","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/jm0304865","volume":"47","author":"JJ Li","year":"2004","unstructured":"Li JJ, Chao HG, Wang H, et al. Discovery of a potent and novel motilin agonist. J Med Chem. 2004;47:1704\u20131708.","journal-title":"J Med Chem"},{"key":"4679_CR80","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/bph.13475","volume":"173","author":"PM Hellstrom","year":"2016","unstructured":"Hellstrom PM, Tack J, Johnson LV, et al. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal in type 1 diabetes mellitus with slow gastric emptying. Br J Pharmacol. 2016;173:1768\u20131777.","journal-title":"Br J Pharmacol"},{"key":"4679_CR81","doi-asserted-by":"crossref","first-page":"S-20","DOI":"10.1016\/S0016-5085(14)60070-6","volume":"146","author":"ME Barton","year":"2014","unstructured":"Barton ME, Otiker T, Johnson LV, et al. A randomized, double-blind, placebo-controlled phase II study (MOT114479) to evaluate the safety and efficacy and dose response of 28\u00a0days of orally administered camicinal in diabetics with gastroparesis. Gastroenterology. 2014;146:S-20.","journal-title":"Gastroenterology"},{"key":"4679_CR82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.vph.2012.11.002","volume":"58","author":"DT Beattie","year":"2013","unstructured":"Beattie DT, Higgins DL, Ero MP, et al. An in vitro investigation of the cardiovascular effects of the 5-HT4 receptor selective agonists, Velusetrag and TD-8954. Vascul Pharmacol. 2013;58:150\u2013156.","journal-title":"Vascul Pharmacol"},{"key":"4679_CR83","doi-asserted-by":"crossref","first-page":"42-e8","DOI":"10.1111\/j.1365-2982.2009.01378.x","volume":"22","author":"ML Manini","year":"2010","unstructured":"Manini ML, Camilleri M, Goldberg M, et al. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in heath and constipation. Neurogastroenterol Motil. 2010;22:42-e8.","journal-title":"Neurogastroenterol Motil"},{"key":"4679_CR84","doi-asserted-by":"crossref","first-page":"S-736","DOI":"10.1016\/S0016-5085(13)62732-8","volume":"144","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T, Tajimi M, Takahashi N, Nii T, Zai H. First-in-human study of the novel 5-HT4 agonist, RQ-00000010, demonstrated acceleration of gastric emptying following single and multiple oral administration to healthy human subjects. Gastroenterology. 2013;144:S-736.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4679-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4679-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4679-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:23:52Z","timestamp":1750775032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4679-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4679"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4679-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,18]]}}}